Global

Apr 01, 2012
Pharmaceutical Executive
India's most prominent scientist, Dr R.A. Mashelkar, President of the Global Research Alliance, on delivering medicines profitably but cheaply to low income countries.
Feb 01, 2012
From Pharmaceutical Technology
By Pharmaceutical Executive Editors
With Europe's economic troubles causing domestic profitability concerns, established pharmaceutical companies may need look to emerging markets for outsourcing partners.
Jan 01, 2012
Pharmaceutical Executive
By Pharmaceutical Executive Editors
The challenge for 2012 is that many new treatments may not complete the move from 'bench to bedside' in time to plug the yawning revenue gap.
Dec 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Will big investments in infrastructure carry the day in positioning China as a global drug innovation powerhouse?
Dec 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
It's a neck and neck race toward safer, faster, and medically superior treatments. Which organizations have what it takes to jockey their products into the winner's circle?
Oct 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Sir Michael Rawlins, Chairman of the UK National Institute for Health and Clinical Excellence
Oct 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Y.K. Hamied, PhD, Chairman, Cipla
Aug 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
HTAs are gridlocked by diverse national requirements, a lack of alignment on processes, and even on the value of their outcomes.
Aug 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
When it comes to the emerging markets, executing a few key elements of success are more important than ever.
Jul 01, 2011
Pharmaceutical Executive
By Pharmaceutical Executive Editors
While Europe's EFPIA preaches about embracing change, much remains to be done to prove the adjustment in philosophy
native1_300x100
lorem ipsum